Mark Jones is an associate in Cooley’s corporate practice. Mark acts on a range of matters for high growth companies, investors, entrepreneurs/founders and management teams, with particular expertise on mergers and acquisitions, private equity, emerging companies/venture capital and corporate re-organisations.

Download full bio 

Experience

  • Snyk Hits $8.5 Billion Valuation With Series F Round 

  • Calypso Technology, Inc. on its sale to Thoma Bravo 

  • Snyk $300 million Series E Financing 

  • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab 

  • Immunocore – $297 Million IPO 

  • View all

Passions

    Travelling

    Sports

    Books

Education

  • University of Law, London Moorgate
    LPC, Distinction, 2014

  • University of Liverpool
    LLB , Honours, 2011

Rankings & Accolades

    The Legal 500 UK: M&A (2022)